ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Passage Bio receives $115m in funding to address CNS diseases pharmaceutical-technology
February 18, 2019Gene therapy company Passage Bio has launched in the US with $115.5m series A funding to develop AAV-delivered therapies for the treatment of rare monogenic central nervous system (CNS) disorders.....
Pharma Sources Insight January 2025
